Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amaranth Medical developed a proprietary platform for fully bioresorbable vascular scaffolds designed to provide temporary arterial support after interventional procedures without leaving permanent implants. Their lead products included the FORTITUDE®, APTITUDE®, MAGNITUDE®, and DEFIANCE™ sirolimus-eluting scaffolds. The company completed several international multi-center trials with positive early imaging and safety data but did not reach commercialization before becoming inactive. Investors included Boston Scientific and several venture funds. Headquarters were located in Mountain View, California with R&D/manufacturing also in Singapore. Kamal Ramzipoor served as CEO during its active years.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amaranth Medical.